Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Journal of Gastrointestinal Surgery
Erschienen in: Journal of Gastrointestinal Surgery 3/2017

12.01.2017 | Original Article

Emergent Colectomy Is Independently Associated with Decreased Long-Term Overall Survival in Colon Cancer Patients

verfasst von: Zhaomin Xu, Adan Z. Becerra, Christopher T. Aquina, Bradley J. Hensley, Carla F. Justiniano, Courtney Boodry, Alex A. Swanger, Reza Arsalanizadeh, Katia Noyes, John R. Monson, Fergal J. Fleming

Erschienen in: Journal of Gastrointestinal Surgery | Ausgabe 3/2017

Einloggen, um Zugang zu erhalten

Abstract

Background

The purpose of this study was to examine the long-term overall survival (OS) of colon cancer patients who underwent emergent resection versus patients who were resected electively.

Methods

The 2006–2012 National Cancer Data Base was queried for colon cancer patients who underwent surgical resection. Emergent resection was defined as resection within 24 h of diagnosis. A mixed-effects logistic regression was used to estimate the effect of emergent resection on 30- and 90-day mortality. A propensity score-matched mixed-effects Cox proportional-hazards model was used to estimate the effect of emergent resection on 5-year OS.

Results

Two hundred fourteen thousand one hundred seventy-four patients met inclusion criteria, 30% of the cohort had an emergent resection. After controlling for patient and hospital factors, pathological stage, lymph node yield, margin status, and adjuvant chemotherapy, emergent resection was associated with increased odds of 30-day mortality (OR = 1.69, 95% CI = 1.60, 1.78) and hazard of death at 5 years (HR = 1.13, 95% CI = 1.09, 1.15) compared to elective resections.

Conclusion

Emergent resection for colon cancer is independently associated with poor short-term outcomes and decreased 5-year OS compared to elective resection. With 30% of cases in this study emergent, these findings underlie the importance of adherence to colon cancer screening guidelines to limit the need for emergent resections.
Literatur
1.
R. Kermani, J. J. Coury, H. Dao, J. H. Lee, P. E. Miller, D. Yee, C. Contant, and A. W. Hackford, “A Practical Mortality Risk Score for Emergent Colectomy:,” Dis. Colon Rectum, vol. 56, no. 4, pp. 467–474, Apr. 2013.
2.
D. A. Klima, R. A. Brintzenhoff, N. Agee, A. Walters, B. T. Heniford, and G. Mostafa, “A Review of Factors that Affect Mortality Following Colectomy,” J. Surg. Res., vol. 174, no. 2, pp. 192–199, May 2012.
3.
A. N. Kulaylat, P. W. Dillon, C. S. Hollenbeak, and D. B. Stewart, “Determinants of 30-d readmission after colectomy,” J. Surg. Res., vol. 193, no. 2, pp. 528–535, Feb. 2015.
4.
J. Kim, R. Mittal, V. Konyalian, J. King, M. J. Stamos, and R. R. Kumar, “Outcome analysis of patients undergoing colorectal resection for emergent and elective indications,” Am. Surg., vol. 73, no. 10, pp. 991–993, 2007.PubMed
5.
R. Siegel, C. DeSantis, and A. Jemal, “Colorectal cancer statistics, 2014: Colorectal Cancer Statistics, 2014,” CA. Cancer J. Clin., vol. 64, no. 2, pp. 104–117, Mar. 2014.
6.
H. Gunnarsson, A. Ekholm, and L. I. Olsson, “Emergency presentation and socioeconomic status in colon cancer,” Eur. J. Surg. Oncol. EJSO, vol. 39, no. 8, pp. 831–836, Aug. 2013.
7.
I. Sucullu, Y. Ozdemir, M. Cuhadar, A. Z. Balta, E. Yucel, A. I. Filiz, and B. Gulec, “Comparison of emergency surgeries for obstructed colonic cancer with elective surgeries: A retrospective study,” Pak. J. Med. Sci., vol. 31, no. 6, pp. 1322–1327, 2015.PubMedPubMedCentral
8.
M. Chand, M. R. Siddiqui, A. Gupta, S. Rasheed, P. Tekkis, A. Parvaiz, A. H. Mirnezami, and T. Qureshi, “Systematic review of emergent laparoscopic colorectal surgery for benign and malignant disease,” World J. Gastroenterol. WJG, vol. 20, no. 45, pp. 16956–16963, Dec. 2014.
9.
A. K. Aslar, S. Özdemir, H. Mahmoudi, and M. A. Kuzu, “Analysis of 230 Cases of Emergent Surgery for Obstructing Colon Cancer—Lessons Learned,” J. Gastrointest. Surg., vol. 15, no. 1, pp. 110–119, Jan. 2011.
10.
D. O. Kavanagh, B. Nolan, C. Judge, J. M. P. Hyland, H. E. Mulcahy, P. R. O’Connell, D. C. Winter, and G. A. Doherty, “A Comparative Study of Short- and Medium-term Outcomes Comparing Emergent Surgery and Stenting as a Bridge to Surgery in Patients With Acute Malignant Colonic Obstruction:,” Dis. Colon Rectum, vol. 56, no. 4, pp. 433–440, Apr. 2013.
11.
B.-H. Kye, Y. S. Lee, H.-M. Cho, J.-G. Kim, S.-T. Oh, I. K. Lee, W. K. Kang, C.-H. Ahn, S. C. Lee, J.-K. Park, and H.-J. Kim, “Comparison of Long-Term Outcomes Between Emergency Surgery and Bridge to Surgery for Malignant Obstruction in Right-Sided Colon Cancer: A Multicenter Retrospective Study,” Ann. Surg. Oncol., Jan. 2016.
12.
A. Matsuda, M. Miyashita, S. Matsumoto, T. Matsutani, N. Sakurazawa, G. Takahashi, T. Kishi, and E. Uchida, “Comparison of Long-Term Outcomes of Colonic Stent as ‘Bridge to Surgery’ and Emergency Surgery for Malignant Large-Bowel Obstruction: A Meta-Analysis,” Ann. Surg. Oncol., vol. 22, no. 2, pp. 497–504, Feb. 2015.
13.
R. Amri, L. G. Bordeianou, P. Sylla, and D. L. Berger, “Colon cancer surgery following emergency presentation: effects on admission and stage-adjusted outcomes,” Am. J. Surg., vol. 209, no. 2, pp. 246–253, Feb. 2015.
14.
S. Biondo, J. Martí-Ragué, E. Kreisler, D. Parés, A. Martín, M. Navarro, L. Pareja, and E. Jaurrieta, “A prospective study of outcomes of emergency and elective surgeries for complicated colonic cancer,” Am. J. Surg., vol. 189, no. 4, pp. 377–383, Apr. 2005.
15.
S. K. C. Wong, B. B. Jalaludin, M. J. Morgan, A. S. Berthelsen, A. Morgan, A. H. Gatenby, and S. B. Fulham, “Tumor Pathology and Long-Term Survival in Emergency Colorectal Cancer:,” Dis. Colon Rectum, vol. 51, no. 2, pp. 223–230, Feb. 2008.
16.
A. C. Surgeons, “Facility Oncology Registry Data Standards: January 1, 2016.” 09-Mar-2016.
17.
R. A. Deyo, D. C. Cherkin, and M. A. Ciol, “Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases.,” Journal of Clinical Epidemiology, vol. 46, no. 6, pp. 613–619, 1992.CrossRef
18.
P. C. Austin, “The use of propensity score methods with survival or time-to-event outcomes: reporting measures of effect similar to those used in randomized experiments: Propensity scores and survival analysis,” Stat. Med., vol. 33, no. 7, pp. 1242–1258, Mar. 2014.
19.
J. D. Hadfield and others, “MCMC methods for multi-response generalized linear mixed models: the MCMCglmm R package,” J. Stat. Softw., vol. 33, no. 2, pp. 1–22, 2010.
20.
D. Ho, K. Imai, G. King, and E. Stuart, “MatchIT: Nonparametric Preprocessing for Parametric Causal Inference,” J. Stat. Softw., vol. 42, no. 8, 2011.
21.
T. M. Therneau and M. T. M. Therneau, “Package ‘coxme,’” Mix. Eff. Cox Models R Package Version, vol. 2, 2015.
22.
A. Polednak, “Inpatient hospital admission through an emergency department in relation to stage at diagnosis of colorectal cancer,” Cancer Detect Prev, vol. 24, no. 3, pp. 283–9, 2000.PubMed
23.
B. Weixler, R. Warschkow, M. Ramser, R. Droeser, U. von Holzen, D. Oertli, and C. Kettelhack, “Urgent surgery after emergency presentation for colorectal cancer has no impact on overall and disease-free survival: a propensity score analysis,” BMC Cancer, vol. 16, no. 1, Dec. 2016.
24.
A. Manning, R. Waldron, and K. Barry, “Poor awareness of colorectal cancer symptoms; a preventable cause of emergency and late stage presentation,” Ir J Med Sci, vol. 175, no. 4, pp. 55–7, 2006.CrossRef
25.
G. Bass, C. Fleming, J. Conneely, Z. Martin, and K. Mealy, “Emergency First Presentation of Colorectal Cancer Predicts Significantly Poorer Outcomes: A Review of 356 Consecutive Irish Patients,” Dis. Colon Rectum, vol. 52, no. 4, pp. 678–684, Apr. 2009.
26.
J. H. Park, D. G. Watt, C. S. Roxburgh, P. G. Horgan, and D. C. McMillan, “Colorectal cancer, systemic inflammation, and outcome: staging the tumor and staging the host,” Ann. Surg., vol. 263, no. 2, pp. 326–336, 2016.CrossRefPubMed
27.
W.-S. Lee, J.-H. Baek, D. H. You, and M. J. Nam, “Prognostic value of circulating cytokines for stage III colon cancer,” J. Surg. Res., vol. 182, no. 1, pp. 49–54, Jun. 2013.
28.
J. E. M. Crozier, E. F. Leitch, R. F. McKee, J. H. Anderson, P. G. Horgan, and D. C. McMillan, “Relationship between emergency presentation, systemic inflammatory response, and cancer-specific survival in patients undergoing potentially curative surgery for colon cancer,” Am. J. Surg., vol. 197, no. 4, pp. 544–549, Apr. 2009.
29.
J. Hogan, K. H. Chang, G. Duff, G. Samaha, N. Kelly, M. Burton, E. Burton, and J. C. Coffey, “Lymphovascular Invasion: A Comprehensive Appraisal in Colon and Rectal Adenocarcinoma,” Dis. Colon Rectum, vol. 58, no. 6, pp. 547–555, Jun. 2015.
30.
S.-B. Lim, C. S. Yu, S. J. Jang, T. W. Kim, J. H. Kim, and J. C. Kim, “Prognostic Significance of Lymphovascular Invasion in Sporadic Colorectal Cancer:,” Dis. Colon Rectum, vol. 53, no. 4, pp. 377–384, Apr. 2010.
31.
M. Norwood, A. Sutton, K. West, D. Sharpe, D. Hemingway, and M. Kelly, “Lymph node retrieval in colorectal cancer resection specimens: national standards are achievable, and low numbers are associated with reduced survival,” Colorectal Dis, vol. 12, no. 4, pp. 304–9, 2010.CrossRefPubMed
32.
J. R. Jass, M. J. O’Brien, R. H. Riddell, and D. C. Snover, “Recommendations for the reporting of surgically resected specimens of colorectal carcinoma,” Hum. Pathol., vol. 38, no. 4, p. 537–545.e3, Apr. 2007.
33.
S. B. Edge and C. C. Compton, “The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM,” Ann. Surg. Oncol., vol. 17, no. 6, pp. 1471–1474, Jun. 2010.
34.
E. Bokey, P. Chapuis, O. Dent, B. Mander, I. Bissett, and R. Newland, “Surgical technique and survival in patients having a curative resection for colon cancer,” Colon Rectum, vol. 46, no. 7, pp. 860–6, 2003.CrossRef
35.
N. P. West, H. Kobayashi, K. Takahashi, A. Perrakis, K. Weber, W. Hohenberger, K. Sugihara, and P. Quirke, “Understanding Optimal Colonic Cancer Surgery: Comparison of Japanese D3 Resection and European Complete Mesocolic Excision With Central Vascular Ligation,” J. Clin. Oncol., vol. 30, no. 15, pp. 1763–1769, May 2012.
36.
A. Z. Becerra, C. P. Probst, M. A. Tejani, C. T. Aquina, M. G. González, B. J. Hensley, K. Noyes, J. R. T. Monson, and F. J. Fleming, “Opportunity lost: Adjuvant chemotherapy in patients with stage III colon cancer remains underused,” Surgery, vol. 158, no. 3, pp. 692–699, Sep. 2015.
37.
E. Quintero, A. Castells, L. Bujanda, J. Cubiella, D. Salas, Á. Lanas, M. Andreu, F. Carballo, J. D. Morillas, C. Hernández, and others, “Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening,” N. Engl. J. Med., vol. 366, no. 8, pp. 697–706, 2012.
38.
M. Kaminski, M. Bretthauer, A. Zauber, E. Kuipers, H.-O. Adami, M. van Ballegooijen, J. Regula, M. van Leerdam, T. Stefansson, L. Påhlman, E. Dekker, M. Hernán, K. Garborg, G. Hoff, and for the NordICC Study Group, “The NordICC Study: Rationale and design of a randomized trial on colonoscopy screening for colorectal cancer,” Endoscopy, vol. 44, no. 7, pp. 695–702, Jul. 2012.
39.
S. Gupta, S. Miller, M. Koch, E. Berry, P. Anderson, S. L. Pruitt, E. Borton, A. E. Hughes, E. Carter, S. Hernandez, H. Pozos, E. A. Halm, A. Gneezy, A. J. Lieberman, C. Sugg Skinner, K. Argenbright, and B. Balasubramanian, “Financial Incentives for Promoting Colorectal Cancer Screening: A Randomized, Comparative Effectiveness Trial,” Am. J. Gastroenterol., Aug. 2016.
40.
R. Pande, E. Leung, P. McCullough, S. Smith, and C. Harmston, “Impact of the United Kingdom National Bowel Cancer Awareness Campaign on Colorectal Services:,” Dis. Colon Rectum, vol. 57, no. 1, pp. 70–75, Jan. 2014.
41.
K. Gellert, K. L. Braun, R. Morris, and V. Starkey, “TheOhana Day Project: a community approach to increasing cancer screening,” Prev Chronic Ser. Online, 2006.
42.
US Preventive Services Task Force, K. Bibbins-Domingo, D. C. Grossman, S. J. Curry, K. W. Davidson, J. W. Epling, F. A. R. García, M. W. Gillman, D. M. Harper, A. R. Kemper, A. H. Krist, A. E. Kurth, C. S. Landefeld, C. M. Mangione, D. K. Owens, W. R. Phillips, M. G. Phipps, M. P. Pignone, and A. L. Siu, “Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement,” JAMA, vol. 315, no. 23, p. 2564, Jun. 2016.
Metadaten
Titel
Emergent Colectomy Is Independently Associated with Decreased Long-Term Overall Survival in Colon Cancer Patients
verfasst von
Zhaomin Xu
Adan Z. Becerra
Christopher T. Aquina
Bradley J. Hensley
Carla F. Justiniano
Courtney Boodry
Alex A. Swanger
Reza Arsalanizadeh
Katia Noyes
John R. Monson
Fergal J. Fleming
Publikationsdatum
12.01.2017
Verlag
Springer US
Erschienen in
Journal of Gastrointestinal Surgery / Ausgabe 3/2017
Print ISSN: 1091-255X
Elektronische ISSN: 1873-4626
DOI
https://doi.org/10.1007/s11605-017-3355-8

Weitere Artikel der Ausgabe 3/2017

Journal of Gastrointestinal Surgery 3/2017 Zur Ausgabe

GI Image

Gastric Outlet Obstruction due to Gastrointestinal Amyloidosis

How I do it

Performing the Difficult Cholecystectomy Using Combined Endoscopic and Robotic Techniques: How I Do It

How I do it

Transhepatic Hilar Approach for Perihilar Cholangiocarcinoma: Significance of Early Judgment of Resectability and Safe Vascular Reconstruction

Original Article

Pattern of Venous Collateral Development after Splenic Vein Occlusion in an Extended Whipple Procedure (Whipple at the Splenic Artery) and Long-Term Results

Original Article

Tri-comparison of Laparoscopic Nissen, Hill, and Nissen-Hill Hybrid Repairs for Uncomplicated Gastroesophageal Reflux Disease

Original Article

Poor Glycemic Control Is Associated with Failure to Complete Neoadjuvant Therapy and Surgery in Patients with Localized Pancreatic Cancer

Neu im Fachgebiet Chirurgie

23.04.2024 | Ablationstherapie | Nachrichten

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 | Appendizitis | Nachrichten

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 | Operationsvorbereitung | Nachrichten

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

19.04.2024 | EAU 2024 | Kongressbericht | Nachrichten

Ureterstriktur: Innovative OP-Technik bewährt sich
weitere anzeigen

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.